U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
153601153601Satisfaction and Compliance of Risedronate in PMOCompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: Risedronate Sodiumhttps://ClinicalTrials.gov/show/NCT00549965
153602153602Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer PatientsRecruitingNo Results AvailableOral MucositisOther: no intervention studyhttps://ClinicalTrials.gov/show/NCT00549952
153603153603Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCompletedHas ResultsNeurogenic Urinary BladderDrug: Alfuzosin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00549939
153604153604Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)CompletedNo Results AvailableCoronary Disease|HypercholesterolemiaDrug: Fluvastatin|Drug: Pravastatin|Drug: Pitavastatin|Drug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT00549926
153605153605Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)CompletedNo Results AvailableDegenerative Disc Disease|Spondylolisthesis|Spinal StenosisGenetic: NeoFuse|Procedure: posterolateral spinal fusion with instrumentationhttps://ClinicalTrials.gov/show/NCT00549913
153606153606A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese FemalesCompletedHas ResultsHuman Papillomavirus (HPV) Infection|Papillomavirus VaccinesBiological: GSK580299 (Cervarixâ„¢ , HPV -16/18 L1 VLP AS04 vaccine)https://ClinicalTrials.gov/show/NCT00549900
153607153607An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching InsulinCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Analog or Human Insulinhttps://ClinicalTrials.gov/show/NCT00549887
153608153608Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesDrug: Rosiglitazone|Drug: Glyburidehttps://ClinicalTrials.gov/show/NCT00549874
153609153609Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMRCompletedNo Results AvailableCardiomyopathy, Dilated|Cardiomyopathies, SecondaryProcedure: Cardiac Magnetic Resonance studyhttps://ClinicalTrials.gov/show/NCT00549861
153610153610Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaRecruitingNo Results AvailableAcute Lymphoblastic LeukemiaDrug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine|Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinibhttps://ClinicalTrials.gov/show/NCT00549848
153611153611Acupuncture for Mucositis Pain in Cancer CareWithdrawnNo Results AvailableMucositis|Pain|LeukemiaProcedure: Real Acupuncture|Procedure: Sham Acupuncturehttps://ClinicalTrials.gov/show/NCT00549835
153612153612Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Letrozolehttps://ClinicalTrials.gov/show/NCT00549822
153613153613Comparison Between IMV and SIMV/PS for Ventilatory Support of Children: a Randomized Clinical TrialCompletedNo Results AvailableRespiratory FailureProcedure: Intermittent mandatory ventilation (IMV) and synchronous IMVhttps://ClinicalTrials.gov/show/NCT00549809
153614153614Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac SurgeryCompletedNo Results AvailableCoronary Arteriosclerosis|Angina PectorisOther: Percutaneous coronary intervention (PCI)https://ClinicalTrials.gov/show/NCT00549796
153615153615BOTOX® Economic Spasticity Trial (BEST)CompletedHas ResultsMuscle SpasticityBiological: Botulinum Toxin Type A 900kD|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00549783
153616153616Efficacy and Safety of LCZ696A in Patients With Essential HypertensionCompletedHas ResultsHypertensionDrug: LCZ696|Drug: Valsartan|Drug: AHU377|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00549770
153617153617Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)TerminatedHas ResultsType 2 Diabetes Mellitus|Cardiovascular DiseaseDrug: Aliskiren|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00549757
153618153618Clinical Endpoint Trial Investigating Once Daily and Bronchodilator DosingCompletedNo Results AvailableAsthma|Mild AsthmaDrug: GSK256066https://ClinicalTrials.gov/show/NCT00549744
153619153619Participant Database for Autism Research StudiesRecruitingNo Results AvailableAutism Spectrum Disorder|Developmental Language Disordershttps://ClinicalTrials.gov/show/NCT00549731
153620153620Lurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaCompletedHas ResultsSchizophreniaDrug: Lurasidone HClhttps://ClinicalTrials.gov/show/NCT00549718
153621153621Registry of Hospitalized Patients Treated With FondaparinuxCompletedNo Results AvailableDeep Vein Thrombosis|Pulmonary Embolismhttps://ClinicalTrials.gov/show/NCT00549705
153622153622Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A NephropathyCompletedNo Results AvailableIgA NephropathyDrug: Omega-3 fatty acid ethylester90https://ClinicalTrials.gov/show/NCT00549692
153623153623Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: GSK256066|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00549679
153624153624A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female SubjectsCompletedNo Results AvailablePharmacokineticsDrug: Lurasidone 40 mg|Drug: Placebo 40 mg|Drug: Ortho Tri-Cyclenhttps://ClinicalTrials.gov/show/NCT00549666
153625153625A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy MenCompletedNo Results AvailableAtherosclerosis|Cardiovascular DiseaseDrug: GW856553https://ClinicalTrials.gov/show/NCT00549653
153626153626Testing Methylphenidate for Smoking AbstinenceCompletedHas ResultsSmokingDrug: Methylphenidate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00549640
153627153627Evaluation of the PediGuardâ„¢ for Pedicle Screw InsertionSuspendedNo Results AvailablePosterior Spinal FusionDevice: Pediguardhttps://ClinicalTrials.gov/show/NCT00549627
153628153628Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart FailureCompletedNo Results AvailableHeart FailureDrug: acipimox|Drug: placebohttps://ClinicalTrials.gov/show/NCT00549614
153629153629Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's DiseaseCompletedHas ResultsAlzheimer's DiseaseDrug: Rivastigmine patch (4.6 mg/day switch to 9.5 mg/day)|Drug: Rivastigmine patch (9.5 mg/day)|Drug: Rivastigmine capsules (6 mg to 12 mg/day)https://ClinicalTrials.gov/show/NCT00549601
153630153630Sunscreen and After-sun-lotion Protection in Polymorphic Light EruptionCompletedNo Results AvailablePolymorphic Light EruptionOther: After-sun-lotion with DNA repair enzymes|Other: SPF30 sunscreen|Other: Placebo after-sun-lotion|Other: Intervention: none (only UV)https://ClinicalTrials.gov/show/NCT00549588

* Görseller ve İçerik tekif hakkına sahip olabilir